Chronic Kidney Disease | Current Treatment | US | 2016
The United States has seen a dramatic rise in the prevalence of chronic kidney disease (CKD) and its sequelae—namely, diabetes and hypertension. Patients with CKD are typically co-managed by many different physician types, including nephrologists, endocrinologists, and primary care physicians (PCPs). Understanding referrals patterns between these physicians for both early- and late-stage CKD patients generates greater insight into patient management, including treatment and prescribing practices. This content stream explores how early- and late-stage CKD-ND patients are referred, co-managed, diagnosed, and treated.
Related Market Assessment Reports
Report
Non-Hodgkin’s Lymphoma and Chronic Lymphocytic Leukemia – Current Treatment – Current Treatment: Physician Insights – B-Cell Non-Hodgkin’s Lymphoma (US)
Non-Hodgkin’s lymphoma (NHL) represents a diverse group of hematological malignancies broadly classified into indolent and aggressive subtypes. Patients with aggressive NHL—diffuse large B-cell…
